Combinatorial therapeutics in high-risk infant acute lymphoblastic leukaemia

Research output

Research output per year 2018 2019 2020 2021 2022 2023

• 15 Article
• 2 Review article
• 1 Letter

Research output per year

Research output per year

Search results

• 2019

  Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

  Cheung, L. C., Cruickshank, M. N., Hughes, A. M., Singh, S., Chua, G-A., Ford, J., Ferrari, E., Oommen, J., Malinge, S., Lock, R. B., Kees, U. R. & Kotecha, R. S., 30 Jun 2019, In: Haematologica. 104, 7, p. e300-e303 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Citations (Scopus)